Cancer Survivor Fights to Lower Drug Costs for Ohioans

Julie Turner was just a high school senior when she faced down stage three Hodgkin's disease with treatments so invasive she still manages the effects today. Now, five decades later, she's channeling that fighting spirit into a battle that could ease the financial burden on thousands of cancer patients across Ohio.

Turner volunteers with the American Cancer Society, advocating for Senate Bill 207. The legislation targets a practice called copay accumulators, where insurance companies don't count manufacturer discounts and assistance toward a patient's out-of-pocket maximum.

"The $1,500 a year that the manufacturer of some very important drugs that I take would count toward my out-of-pocket maximum," Turner explained. For someone managing long-term health effects from life-saving cancer treatment, that difference matters.

The stakes are high in Ohio. More than 70,000 people get diagnosed with cancer in the state every year, and it's the second most common cause of death. Each diagnosis brings not just medical challenges but mounting bills that can force impossible choices.

Vince Marchetta, state lead ambassador for the American Cancer Society, emphasizes why this financial relief matters. Patients with less comprehensive insurance coverage get hit hardest by these policies, and the accumulating costs pull focus away from healing.

The Ripple Effect

Senate Bill 207 represents a simple but powerful shift. By requiring insurance companies to count all assistance toward out-of-pocket maximums, the bill puts financial relief back where it belongs: in the hands of patients fighting for their lives.

The legislation addresses a growing problem across the healthcare system. As drug prices climb and insurance rules grow more complex, patients increasingly struggle to access the medications keeping them alive. This bill offers a concrete solution that could quickly impact thousands of families.

Turner's advocacy spans 21 years, but her motivation has evolved. She now has grandchildren, and staying healthy enough to hold them, play with them, and care for them depends on affording her medication. "I want to pick them up. I want to care for them," she said.

The bill awaits committee action, but Turner isn't waiting. She's meeting with elected officials, sharing her story, and making the case that no one should have to choose between financial stability and staying alive.

Her message is clear: the treatments bought her time 51 years ago, and she's using every moment of it to ensure others get the same chance.